ACKR2 and Alzheimer disease: In this study, we observed significant differences in the ability of ACKR2-V41A to bind and scavenge CCL2, potentially resulting in higher levels of CCL2 at the injury site and maintenance of pro-inflammatory signaling and monocyte recruitment, which may lead to increased Aβ plaque aggregation and risk for AD.